Royston Aaron 4
4 · Ventyx Biosciences, Inc. · Filed Oct 25, 2021
Insider Transaction Report
Form 4
Royston Aaron
Director10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-10-25−395,027→ 0 total(indirect: See footnote)→ Common Stock (395,027 underlying) - Conversion
Common Stock
2021-10-25+3,684,769→ 3,684,769 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-10-25−3,289,742→ 0 total(indirect: See footnote)→ Common Stock (3,289,742 underlying) - Purchase
Common Stock
2021-10-25$16.00/sh+312,500$5,000,000→ 3,997,269 total(indirect: See footnote)
Holdings
- 1,014,267(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]All shares of the preferred stock, par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- [F2]Shares held by venBio III. venBio GP is the sole general partner of venBio III. venBio Ltd is the sole general partner of venBio GP. The Reporting Person, Robert Adelman and Corey Goodman are each a director of venBio Ltd and may be deemed to share voting and dispositive power over the shares held by venBio III. The Reporting Person disclaims beneficial ownership over the shares held by venBio III except to the extent of his pecuniary interest therein.
- [F3]Shares held by venBio SPV III, LLC ("venBio SPV"). venBio SPV is wholly owned and managed by venBio Global Strategic Fund III, L.P. ("venBio III"). venBio Global Strategic GP III, L.P., a Cayman Islands partnership ("venBio GP") is the sole general partner of venBio III. venBio Global Strategic GP III, Ltd., a Cayman Islands company ("venBio Ltd") is the sole general partner of venBio GP. The Reporting Person, Robert Adelman and Corey Goodman are each a director of venBio Ltd and may be deemed to share voting and dispositive power over the shares held by venBio SPV. The Reporting Person disclaims beneficial ownership over the shares held by venBio SPV except to the extent of his pecuniary interest therein.